Mechanistic aspects of maltotriose-conjugate translocation to the Gram-negative bacteria cytoplasm

A maltotriose-conjugate can deliver molecules into the cytoplasmic space of Gram-negative bacteria by parasitizing the maltose uptake pathway. Small molecule accumulation in Gram-negative bacteria is a key challenge to discover novel antibiotics, because of their two membranes and efflux pumps expelling toxic molecules. An approach to overcome this challenge is to hijack uptake pathways so that bacterial transporters shuttle the antibiotic to the cytoplasm. Here, we have characterized maltodextrin–fluorophore conjugates that can pass through both the outer and inner membranes mediated by components of the Escherichia coli maltose regulon. Single-channel electrophysiology recording demonstrated that the compounds permeate across the LamB channel leading to accumulation in the periplasm. We have also demonstrated that a maltotriose conjugate distributes into both the periplasm and cytoplasm. In the cytoplasm, the molecule activates the maltose regulon and triggers the expression of maltose binding protein in the periplasmic space indicating that the complete maltose entry pathway is induced. This maltotriose conjugate can (i) reach the periplasmic and cytoplasmic compartments to significant internal concentrations and (ii) auto-induce its own entry pathway via the activation of the maltose regulon, representing an interesting prototype to deliver molecules to the cytoplasm of Gram-negative bacteria.

[1]  B. Cinquin,et al.  Spectrofluorimetric quantification of antibiotic drug concentration in bacterial cells for the characterization of translocation across bacterial membranes , 2018, Nature Protocols.

[2]  N. Murthy,et al.  A Trimethoprim Conjugate of Thiomaltose Has Enhanced Antibacterial Efficacy In Vivo. , 2018, Bioconjugate chemistry.

[3]  G. Zhanel,et al.  Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens? , 2018, Clinical Microbiology Reviews.

[4]  M. Schäfers,et al.  Harnessing the Maltodextrin Transport Mechanism for Targeted Bacterial Imaging: Structural Requirements for Improved in vivo Stability in Tracer Design , 2018, ChemMedChem.

[5]  Urs O. Häfeli,et al.  Metal nanoparticles: understanding the mechanisms behind antibacterial activity , 2017, Journal of Nanobiotechnology.

[6]  Asad U. Khan,et al.  Nano-therapeutics: A revolution in infection control in post antibiotic era. , 2017, Nanomedicine : nanotechnology, biology, and medicine.

[7]  B. Cinquin,et al.  Fluoroquinolone structure and translocation flux across bacterial membrane , 2017, Scientific Reports.

[8]  M. Brönstrup,et al.  Bifunctional antimicrobial conjugates and hybrid antimicrobials. , 2017, Natural product reports.

[9]  Christopher H Contag,et al.  Specific Imaging of Bacterial Infection Using 6″-18F-Fluoromaltotriose: A Second-Generation PET Tracer Targeting the Maltodextrin Transporter in Bacteria , 2017, The Journal of Nuclear Medicine.

[10]  I. Schalk,et al.  Bacterial Iron Uptake Pathways: Gates for the Import of Bactericide Compounds. , 2017, Journal of medicinal chemistry.

[11]  J. Pagés,et al.  Erratum: Unusual marine unicellular symbiosis with the nitrogen-fixing cyanobacterium UCYN-A , 2017, Nature Microbiology.

[12]  R. Hancock,et al.  Polymyxin: Alternative Mechanisms of Action and Resistance. , 2016, Cold Spring Harbor perspectives in medicine.

[13]  M. Winterhalter,et al.  Role of Electroosmosis in the Permeation of Neutral Molecules: CymA and Cyclodextrin as an Example. , 2016, Biophysical journal.

[14]  R. Laxminarayan,et al.  Access to effective antimicrobials: a worldwide challenge , 2016, The Lancet.

[15]  B. Cinquin,et al.  Microspectrometric insights on the uptake of antibiotics at the single bacterial cell level , 2015, Scientific Reports.

[16]  David Brown,et al.  Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void? , 2015, Nature Reviews Drug Discovery.

[17]  S Gnanakaran,et al.  Permeability Barrier of Gram-Negative Cell Envelopes and Approaches To Bypass It. , 2015, ACS infectious diseases.

[18]  Hiroshi Nikaido,et al.  The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria , 2015, Clinical Microbiology Reviews.

[19]  M. Webber,et al.  Molecular mechanisms of antibiotic resistance , 2014, Nature Reviews Microbiology.

[20]  M. Winterhalter,et al.  TRANSLOCATION Project: How to Get Good Drugs into Bad Bugs , 2014, Science Translational Medicine.

[21]  I. Schalk,et al.  Siderophore-dependent iron uptake systems as gates for antibiotic Trojan horse strategies against Pseudomonas aeruginosa. , 2014, Metallomics : integrated biometal science.

[22]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[23]  J. Pagés,et al.  Antibiotic Transport in Resistant Bacteria: Synchrotron UV Fluorescence Microscopy to Determine Antibiotic Accumulation with Single Cell Resolution , 2012, PloS one.

[24]  H. Nikaido,et al.  Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria. , 2012, FEMS microbiology reviews.

[25]  Dongin Kim,et al.  Maltodextrin-based imaging probes detect bacteria in vivo with high sensitivity and specificity. , 2011, Nature materials.

[26]  J. Handzlik,et al.  Strategies for bypassing the membrane barrier in multidrug resistant Gram‐negative bacteria , 2011, FEBS letters.

[27]  Nico Stuurman,et al.  Computer Control of Microscopes Using µManager , 2010, Current protocols in molecular biology.

[28]  Emily S. Charlson,et al.  Dissection of β‐barrel outer membrane protein assembly pathways through characterizing BamA POTRA 1 mutants of Escherichia coli , 2010, Molecular microbiology.

[29]  Frank Wien,et al.  Synchrotron UV Fluorescence Microscopy Uncovers New Probes in Cells and Tissues , 2010, Microscopy and Microanalysis.

[30]  Daniel Zerbib,et al.  DISCO: a low-energy multipurpose beamline at synchrotron SOLEIL. , 2009, Journal of synchrotron radiation.

[31]  J. Pagés,et al.  Efflux Pump, the Masked Side of ß-Lactam Resistance in Klebsiella pneumoniae Clinical Isolates , 2009, PloS one.

[32]  J. Bartlett,et al.  Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  M. Winterhalter,et al.  The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria , 2008, Nature Reviews Microbiology.

[34]  J. Pagés,et al.  Membrane permeability and regulation of drug "influx and efflux" in enterobacterial pathogens. , 2008, Current drug targets.

[35]  James T. Park,et al.  How Bacteria Consume Their Own Exoskeletons (Turnover and Recycling of Cell Wall Peptidoglycan) , 2008, Microbiology and Molecular Biology Reviews.

[36]  W. Boos,et al.  The Maltodextrin System of Escherichia coli: Metabolism and Transport , 2005, Journal of bacteriology.

[37]  R. Misra,et al.  YaeT (Omp85) affects the assembly of lipid‐dependent and lipid‐independent outer membrane proteins of Escherichia coli , 2005, Molecular microbiology.

[38]  H. Nikaido Molecular Basis of Bacterial Outer Membrane Permeability Revisited , 2003, Microbiology and Molecular Biology Reviews.

[39]  M. Winterhalter,et al.  Probing the Orientation of Reconstituted Maltoporin Channels at the Single-protein Level* , 2003, Journal of Biological Chemistry.

[40]  I. Pyykkö,et al.  Role of Transtympanic Endoscopy of the Middle Ear in the Diagnosis of Perilymphatic Fistula in Patients with Sensorineural Hearing Loss or Vertigo , 2002, ORL.

[41]  Stefan Fischer,et al.  Translocation mechanism of long sugar chains across the maltoporin membrane channel. , 2002, Structure.

[42]  W. Boos,et al.  Network regulation of the Escherichia coli maltose system. , 2002, Journal of molecular microbiology and biotechnology.

[43]  Winfried Boos,et al.  Maltose/Maltodextrin System of Escherichia coli: Transport, Metabolism, and Regulation , 1998, Microbiology and Molecular Biology Reviews.

[44]  R. Hancock,et al.  The bacterial outer membrane as a drug barrier. , 1997, Trends in microbiology.

[45]  H. Nikaido Outer membrane barrier as a mechanism of antimicrobial resistance , 1989, Antimicrobial Agents and Chemotherapy.

[46]  H. Shinagawa,et al.  Normal precursors of periplasmic proteins accumulated in the cytoplasm are not exported post-translationally in Escherichia coli. , 1984, European journal of biochemistry.

[47]  Alan G. Hawkes,et al.  The Principles of the Stochastic Interpretation of Ion-Channel Mechanisms , 1983 .

[48]  M Montal,et al.  Formation of bimolecular membranes from lipid monolayers and a study of their electrical properties. , 1972, Proceedings of the National Academy of Sciences of the United States of America.